Cat: AB-1002
IL6-Ab2, hIgG1, HEK293 Cells,others: Product Information
Monoclonal anti-human interleukin 6 (IL6)
Detects human IL6 in ELISAs and Western blots. This antibody does not cross-react with recombinant mouse (rm)
IL-6, rhOSM, rhLIF, rhIL-11, rhgp130, or rhCNTF in western blot.
Monoclonal Human IgG1
Recommended pairs in sandwich immunoassays (capture-detection):
AB-1001 & AB-1002
AB-1001M & AB-1002
AB-1002 & AB-1003
Protein A or G chromatography
Dissolved in sterile PBS buffer to a concentration of 0.5 mg/mL.
This solution can be diluted into other aqueous buffers. Centrifuge the vial prior to opening.
Avoid repeated freeze-thaw cycles.
It is recommended that the protein be aliquoted for optimal storage.
12 months from date of receipt, -20 to -70 °C as supplied.
Shipping with dry ice.
> 95%, determined by SDS-PAGE
<0.010 EU per 1 ug of the protein by the LAL method
This product is sold for research or further manufacturing use only. Standard Laboratory Practices should be followed when handling this material.
IL6-Ab2, hIgG1, HEK293 Cells,others: Product Information
IL6-Ab2, hIgG1, HEK293 Cells,others: Product Information
IL6-Ab2, hIgG1, HEK293 Cells,others: Product Information
Interleukin-6 (IL-6) is a multifunctional α-helical cytokine that regulates cell growth and differentiation of various tissues (1, 2). Mature human IL-6 is 183 amino acids in length and shares 39% sequence identity with mouse and rat IL-6 (3). Alternative splicing generates several isoforms with internal deletions, some of which exhibit antagonistic properties (4-7). IL-6 induces signaling through a cell surface heterodimeric receptor complex composed of a ligand binding subunit (IL-6R alpha) and a signal transducing subunit (gp130). IL-6 binds to IL-6R alpha, triggering IL-6R alpha association with gp130 (8). gp130 is also a component of the receptors for CLC, CNTF, CT-1, IL-11, IL-27, LIF, and OSM (9). Soluble forms of IL-6 R alpha are generated by both alternative splicing and proteolytic cleavage (2). In a mechanism known as trans-signaling, complexes of soluble IL-6 and IL-6 R alpha elicit responses from gp130-expressing cells that lack cell surface IL-6 R alpha (2). Trans-signaling enables a wider range of cell types to respond to IL-6, as the expression of gp130 is ubiquitous, while that of IL-6 R alpha is predominantly restricted to hepatocytes, monocytes, and resting lymphocytes (2). Soluble splice forms of gp130 block trans-signaling from IL-6/IL-6 R alpha but not from other cytokines that use gp130 as a co-receptor (2, 10). IL-6, along with TNF-alpha and IL-1, drives the acute inflammatory response and the transition from acute inflammation to either acquired immunity or chronic inflammatory disease (1, 2). When dysregulated, it contributes to chronic inflammation in obesity, insulin resistance, inflammatory bowel disease, arthritis, sepsis, and atherosclerosis (1, 2, 5).
1. Mansell, A. and B.J. Jenkins (2013) Cytokine Growth Factor Rev. 24:249.
2. Mihara, M. et al. (2012) Clin. Sci. (Lond.) 122:143.
3. Hirano, T. et al. (1986) Nature 324:73.
4. Kestler, D.P. et al. (1995) Blood 86:4559.
5. Kestler, D.P. et al. (1999) Am. J. Hematol. 61:169.
6. Bihl, M.P. et al. (2002) Am. J. Respir. Cell Mol. Biol. 27:48.
7. Alberti, L. et al. (2005) Cancer Res. 65:2.
8. Murakami, M. et al. (1993) Science 260:1808.
9. Muller-Newen, G. (2003) Sci. STKE 2003:PE40.
10. Mitsuyama, K. et al. (2006) Clin. Exp. Immunol. 143:125.
hIgG1 IFNγ-Ab2 产品展示
hIgG1 IFNγ-Ab1 产品展示
hIgG1 IFNα-Ab2 产品展示
hIgG1 IFNα-Ab1 产品展示
hIgG1 TNFα-Ab2 产品展示
hIgG1 TNFα-Ab1 产品展示
hIgG1 IL17A-Ab2 产品展示
hIgG1 IL17A-Ab1 产品展示
hIgG1 IL12-Ab2 产品展示
hIgG1 IL12-Ab1 产品展示
hIgG1 IL10-Ab2 产品展示
hIgG1 IL10-Ab1 产品展示
hIgG1 IL8-Ab2 产品展示
hIgG1 IL8-Ab1 产品展示
hIgG1 IL6-Ab2 产品展示
hIgG1 IL6-Ab1 产品展示
hIgG1 IL5-Ab2 产品展示
hIgG1 IL5-Ab1 产品展示
hIgG1 IL4-Ab2 产品展示
hIgG1 IL4-Ab1 产品展示
hIgG1 IL2-Ab2 产品展示
hIgG1 IL1β-Ab2 产品展示
hIgG1 IL1β-Ab1 产品展示
